VHAQ — Viveon Health Acquisition Income Statement
0.000.00%
FinancialsHighly SpeculativeMicro Cap
- $62.22m
- $66.65m
Annual income statement for Viveon Health Acquisition, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | 10-Q | 10-K | 10-K | 10-K |
Standards: | — | USG | USG | USG |
Status: | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 |
Cost of Revenue | ||||
Selling / General / Administrative Expenses | ||||
Unusual Expense / Income | ||||
Other Operating Expenses | ||||
Total Operating Expenses | — | 0.475 | 4.11 | 2.37 |
Operating Profit | 0 | -0.475 | -4.11 | -2.37 |
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | — | -2.24 | 2.49 | -0.425 |
Provision for Income Taxes | ||||
Net Income After Taxes | — | -2.24 | 2.49 | -0.487 |
Net Income Before Extraordinary Items | ||||
Net Income | — | -2.24 | 2.49 | -0.487 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Dilution Adjustment | ||||
Diluted Net Income | 0 | -2.24 | 2.49 | -0.487 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | — | -0.088 | 0.103 | -0.04 |